NILOFAR SARVAIYA: Open Payments
NPI 1134548910 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 32 payments from 7 companies in 2025. Trend: 2023 $173 · 2024 $484 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $263 |
| Alkermes, Inc. | 2 | $154 |
| Teva Pharmaceuticals USA, Inc. | 6 | $120 |
| Braeburn Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: VRAYLAR, VIVITROL, AUSTEDO XR, UZEDY, BRIXADI, CAPLYTA, Auvelity, COBENFY.
Industry payments across NY — which companies pay providers there.
